The Multifaceted Actions of PVP-Curcumin for Treating Infections.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Jun 2024
Historique:
received: 25 04 2024
revised: 23 05 2024
accepted: 29 05 2024
medline: 19 6 2024
pubmed: 19 6 2024
entrez: 19 6 2024
Statut: epublish

Résumé

Curcumin is a natural compound that is considered safe and may have potential health benefits; however, its poor stability and water insolubility limit its therapeutic applications. Different strategies aim to increase its water solubility. Here, we tested the compound PVP-curcumin as a photosensitizer for antimicrobial photodynamic therapy (aPDT) as well as its potential to act as an adjuvant in antibiotic drug therapy. Gram-negative

Identifiants

pubmed: 38892328
pii: ijms25116140
doi: 10.3390/ijms25116140
pii:
doi:

Substances chimiques

Curcumin IT942ZTH98
Photosensitizing Agents 0
Rec A Recombinases EC 2.7.7.-
Ciprofloxacin 5E8K9I0O4U
Anti-Bacterial Agents 0
Escherichia coli Proteins 0
recA protein, E coli 0
Povidone FZ989GH94E
DNA-Binding Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Austrian Research Promotion Agency
ID : 900408

Auteurs

Magdalena Metzger (M)

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.
Institute of Molecular Biotechnology, University of Natural Resources and Life Sciences, 1190 Vienna, Austria.

Stefan Manhartseder (S)

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.

Leonie Krausgruber (L)

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.

Lea Scholze (L)

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.

David Fuchs (D)

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.

Carina Wagner (C)

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.

Michaela Stainer (M)

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.

Johannes Grillari (J)

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.
Institute of Molecular Biotechnology, University of Natural Resources and Life Sciences, 1190 Vienna, Austria.

Andreas Kubin (A)

Planta Naturstoffe Vertriebs GmbH, 1230 Vienna, Austria.

Lionel Wightman (L)

Planta Naturstoffe Vertriebs GmbH, 1230 Vienna, Austria.

Peter Dungel (P)

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Fragaria Light Plant Leaves Osmosis Stress, Physiological

Classifications MeSH